751 related articles for article (PubMed ID: 23851307)
1. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor.
Ribeiro A; Ferraz-de-Paula V; Pinheiro ML; Vitoretti LB; Mariano-Souza DP; Quinteiro-Filho WM; Akamine AT; Almeida VI; Quevedo J; Dal-Pizzol F; Hallak JE; Zuardi AW; Crippa JA; Palermo-Neto J
Eur J Pharmacol; 2012 Mar; 678(1-3):78-85. PubMed ID: 22265864
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation.
Magen I; Avraham Y; Ackerman Z; Vorobiev L; Mechoulam R; Berry EM
J Hepatol; 2009 Sep; 51(3):528-34. PubMed ID: 19596476
[TBL] [Abstract][Full Text] [Related]
4. Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.
Murray PD; Krivacic K; Chernosky A; Wei T; Ransohoff RM; Rodriguez M
J Neurovirol; 2000 May; 6 Suppl 1():S44-52. PubMed ID: 10871765
[TBL] [Abstract][Full Text] [Related]
5. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3.
So EY; Kang MH; Kim BS
Glia; 2006 Jun; 53(8):858-67. PubMed ID: 16586493
[TBL] [Abstract][Full Text] [Related]
6. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
Front Immunol; 2019; 10():1921. PubMed ID: 31497013
[TBL] [Abstract][Full Text] [Related]
7. Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
Giacoppo S; Soundara Rajan T; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4906-19. PubMed ID: 26744883
[TBL] [Abstract][Full Text] [Related]
8. A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
Feliú A; Moreno-Martet M; Mecha M; Carrillo-Salinas FJ; de Lago E; Fernández-Ruiz J; Guaza C
Br J Pharmacol; 2015 Jul; 172(14):3579-95. PubMed ID: 25857324
[TBL] [Abstract][Full Text] [Related]
9. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors.
Mestre L; Iñigo PM; Mecha M; Correa FG; Hernangómez-Herrero M; Loría F; Docagne F; Borrell J; Guaza C
J Neuroinflammation; 2011 Aug; 8():102. PubMed ID: 21851608
[TBL] [Abstract][Full Text] [Related]
10. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
[TBL] [Abstract][Full Text] [Related]
11. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated.
Vincenzi F; Corciulo C; Targa M; Merighi S; Gessi S; Casetta I; Gentile M; Granieri E; Borea PA; Varani K
Eur J Immunol; 2013 Aug; 43(8):2206-16. PubMed ID: 23661562
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.
Navarrete C; Carrillo-Salinas F; Palomares B; Mecha M; Jiménez-Jiménez C; Mestre L; Feliú A; Bellido ML; Fiebich BL; Appendino G; Calzado MA; Guaza C; Muñoz E
J Neuroinflammation; 2018 Mar; 15(1):64. PubMed ID: 29495967
[TBL] [Abstract][Full Text] [Related]
16. Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis.
Ortega-Gutiérrez S; Molina-Holgado E; Arévalo-Martín A; Correa F; Viso A; López-Rodríguez ML; Di Marzo V; Guaza C
FASEB J; 2005 Aug; 19(10):1338-40. PubMed ID: 15941768
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.
Mestre L; Correa F; Arévalo-Martín A; Molina-Holgado E; Valenti M; Ortar G; Di Marzo V; Guaza C
J Neurochem; 2005 Mar; 92(6):1327-39. PubMed ID: 15748152
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites.
Mecha M; Feliú A; Carrillo-Salinas FJ; Mestre L; Guaza C
Exp Neurol; 2013 Dec; 250():348-52. PubMed ID: 24148569
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
Front Immunol; 2018; 9():1782. PubMed ID: 30123217
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis.
González-García C; Torres IM; García-Hernández R; Campos-Ruíz L; Esparragoza LR; Coronado MJ; Grande AG; García-Merino A; Sánchez López AJ
Exp Neurol; 2017 Dec; 298(Pt A):57-67. PubMed ID: 28867485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
